10.05 (0.70%) Cipla has informed about Press Release dated May 27, 2015 titled ‘Cipla announces the next steps in its relationship with Serum Institute-an exclusive distribution agreement for flu vaccine ‘Nasovac-S’ for India’.
The above information is a part of company’s filings submitted to BSE.